Cargando…

Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin

Infections caused by Gram-positive bacteria are a major public health problem due to their increasing resistance to antibiotics. Staphylococcus and Enterococcus species’ resistance and pathogenicity are enhanced by their ability to form biofilm. The biofilm lifestyle represents a significant obstacl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliva, Alessandra, Stefani, Stefania, Venditti, Mario, Di Domenico, Enea Gino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569946/ https://www.ncbi.nlm.nih.gov/pubmed/34745053 http://dx.doi.org/10.3389/fmicb.2021.749685

Ejemplares similares

Effect of Dalbavancin on Staphylococcal Biofilms When Administered Alone or in Combination With Biofilm-Detaching Compounds
por: Žiemytė, Miglë, et al.
Publicado: (2020)

In Vitro Efficacy of Dalbavancin as a Long-Acting Anti-Biofilm Agent Loaded in Bone Cement
por: Sánchez-Somolinos, Mar, et al.
Publicado: (2023)

The Current Knowledge on the Pathogenesis of Tissue and Medical Device-Related Biofilm Infections
por: Di Domenico, Enea Gino, et al.
Publicado: (2022)

Editorial: Microbial Biofilms in Chronic and Recurrent Infections
por: Ascenzioni, Fiorentina, et al.
Publicado: (2021)

Nigericin is effective against multidrug resistant gram-positive bacteria, persisters, and biofilms
por: Zhu, Xiaoli, et al.
Publicado: (2022)

Development of an in vitro Assay, Based on the BioFilm Ring Test(®), for Rapid Profiling of Biofilm-Growing Bacteria
por: Di Domenico, Enea G., et al.
Publicado: (2016)

1553. Efficacy and Safety of Dalbavancin and Oritavancin in the Treatment of Gram-Positive Infections
por: Brown, Vanessa, et al.
Publicado: (2020)

Determining the Targets of Fluopsin C Action on Gram-Negative and Gram-Positive Bacteria
por: Navarro, Miguel Octavio Pérez, et al.
Publicado: (2020)

Repurposing the Sphingosine-1-Phosphate Receptor Modulator Etrasimod as an Antibacterial Agent Against Gram-Positive Bacteria
por: Zore, Matej, et al.
Publicado: (2022)

687. Use of Dalbavancin in Gram-positive Infective Endocarditis: Review of Current Literature
por: Fazili, Tasaduq, et al.
Publicado: (2021)

Flow cytometric evaluation of physico-chemical impact on Gram-positive and Gram-negative bacteria
por: Fröhling, Antje, et al.
Publicado: (2015)

Corrigendum: Determining the Targets of Fluopsin C Action on Gram-Negative and Gram-Positive Bacteria
por: Navarro, Miguel Octavio Pérez, et al.
Publicado: (2020)

Lipoproteins in Gram-Positive Bacteria: Abundance, Function, Fitness
por: Nguyen, Minh-Thu, et al.
Publicado: (2020)

Resistance Mechanisms to Antimicrobial Peptides in Gram-Positive Bacteria
por: Assoni, Lucas, et al.
Publicado: (2020)

Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections
por: Sivori, Francesca, et al.
Publicado: (2022)

Multiple Responses of Gram-Positive and Gram-Negative Bacteria to Mixture of Hydrocarbons
por: Marilena Lăzăroaie, Mihaela
Publicado: (2010)

Stuck in the Middle: Fibronectin-Binding Proteins in Gram-Positive Bacteria
por: Hymes, Jeffrey P., et al.
Publicado: (2016)

Bioactive Products From Plant-Endophytic Gram-Positive Bacteria
por: Ek-Ramos, María J., et al.
Publicado: (2019)

Editorial: Cell Surface Proteins of Gram-Positive Pathogenic Bacteria
por: Hook, Magnus, et al.
Publicado: (2021)

Editorial: Novel research on metabolites secreted by gram-positive bacteria
por: Barboza-Corona, José E., et al.
Publicado: (2023)

Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections
por: Smith, Jordan R., et al.
Publicado: (2015)

Effect of chemical modifications of tannins on their antimicrobial and antibiofilm effect against Gram-negative and Gram-positive bacteria
por: Villanueva, Xabier, et al.
Publicado: (2023)

Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections
por: Poliseno, Mariacristina, et al.
Publicado: (2021)

Structural Insights into Serine-rich Fimbriae from Gram-positive Bacteria
por: Ramboarina, Stéphanie, et al.
Publicado: (2010)

The antibacterial activity of a photoactivatable diarylacetylene against Gram-positive bacteria
por: Waite, Ryan, et al.
Publicado: (2023)

Antibacterial Activity of Stenotrophomonas maltophilia Endolysin P28 against both Gram-positive and Gram-negative Bacteria
por: Dong, Hongling, et al.
Publicado: (2015)

Occurrence of ferredoxin:NAD(+) oxidoreductase activity and its ion specificity in several Gram-positive and Gram-negative bacteria
por: Hess, Verena, et al.
Publicado: (2016)

Gastrointestinal Stability and Cytotoxicity of Bacteriocins From Gram-Positive and Gram-Negative Bacteria: A Comparative in vitro Study
por: Soltani, Samira, et al.
Publicado: (2022)

Glass bead transformation method for gram-positive bacteria
por: Rattanachaikunsopon, Pongsak, et al.
Publicado: (2009)

200. Real-World Experience with Dalbavancin for Complicated Gram-Positive Infections: A Multicenter Evaluation
por: Alosaimy, Sara, et al.
Publicado: (2019)

Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series
por: Evins, Connor, et al.
Publicado: (2022)

Long-term Dalbavancin for Suppression of Gram-Positive Chronic Left Ventricular Assist Device Infections
por: Rowe, Sarah, et al.
Publicado: (2023)

Single-cell scattering and auto-fluorescence-based fast antibiotic susceptibility testing for gram-negative and gram-positive bacteria
por: Dixneuf, Sophie, et al.
Publicado: (2023)

Acinetobacter baumannii in the critically ill: complex infections get complicated
por: Cavallo, Ilaria, et al.
Publicado: (2023)

Genome-wide gene order distances support clustering the gram-positive bacteria
por: House, Christopher H., et al.
Publicado: (2015)

Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria
por: Zimmerman, Tahl, et al.
Publicado: (2019)

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
por: Binyamin, Dana, et al.
Publicado: (2018)

217. Antimicrobial Activity of Dalbavancin against Gram-Positive Bacteria Isolated from Patients Hospitalized with Bacteremia in United States and European Medical Centers: Results from the International Dalbavancin Evaluation of Activity (IDEA) Program (2018-202)
por: Sader, Helio S, et al.
Publicado: (2021)

Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections
por: Bork, Jacqueline T., et al.
Publicado: (2019)

DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m33o746gah8f35rrd828eg6p6s